Lymphangioleiomyomatosis (LAM) is a rare progressive lung disease of reproductive age women. It occurs as an isolated disorder (sporadic LAM) or in an association with tuberous sclerosis complex (TSC). Coexisting renal angiomyolipomas occur in TSC and LAM, and there is an association between TSC and neuroendocrine tumors. Commonly used therapies aimed at decreasing endogenous estrogen in LAM have not been verified by randomized trial.
CASE REPORT
An octreoScan was performed to detect tumors/tissue containing somatostatin receptors (such as neuroendocrine tumors) in a 29 year-old woman with TSC, end-stage renal disease secondary to angiomyolipomas (figure 1), LAM lung (figure 2), and "potato-like" cerebral lesions. Whole body images were obtained 24 hours post IV injection of In-111 pentatreotide 5.5 mCi demonstrating increased uptake of the radio pharmaceutical diffusely in the lung and kidney (figure 3). 
DISCUSSION
This result suggests somatostatin receptor-bearing tissue in TSC/LAM. This observation suggests a novel approach to the detection and monitoring of this disease and possible treatment with octreotide acetate, a cyclic octapeptide with down-regulating properties similar to the natural hormone somatostatin. Further studies addressing the importance of somatostatin receptor in these disorders is warranted.
